ClariTrial | Search Clinical Trials

Explore/HIV Infections

Status

Phase

12,083 results for “HIV Infections”

Page 1 of 806

Completed

Supporting Sustained HIV Treatment Adherence After Initiation

N/AHIV InfectionsAdherence, Medication

M1/OTR: Immediate outreach to subject due to unsuppressed viral load test resultM2/PRM: Immediate outreach to subject after a missed pharmacy refillM3/EAM: Immediate outreach to subject after EAM-identified missed doses+2 more

Boston University534 participants3 sites · South AfricaCompletes May 2026

Compare CT.gov Full analysis →

Active

A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands

N/AHIV InfectionsHIV-1-infectionHIV-2 Infection

Erasmus Medical Center35 participants1 site · NetherlandsCompletes Jan 2027

Compare CT.gov Full analysis →

Completed

Respiratory Virus Outpatient Study (FLU 002 Plus)

N/AInfluenza and Other Novel Respiratory Viruses

University of Minnesota11,719 participants68 sites · United States, Argentina, AustraliaCompletes May 2017

Compare CT.gov Full analysis →

Recruiting

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Phase 2Tuberculosis, Pulmonary

sorfequilinePretomanidLinezolid

Global Alliance for TB Drug Development100 participants12 sites · South Africa, TanzaniaCompletes May 2027

Compare CT.gov Full analysis →

Completed

Results posted

Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

Phase 2Phase 3HIV Infections

Cabotegravir Oral TabletTDF/FTC tabletsPlacebo for TDF/FTC tablets+3 more

National Institute of Allergy and Infectious Diseases (NIAID)4,570 participants43 sites · United States, Argentina, BrazilCompletes May 2020

Compare CT.gov Full analysis →

Completed

Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU

N/AHIV

Individual levelStructural levelIndividual level standard of care+1 more

Johns Hopkins Bloomberg School of Public Health2,175 participants1 site · VietnamCompletes Apr 2013

Compare CT.gov Full analysis →

Completed

Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids

N/AHuman Immunodeficiency Virus Infection

Tenofovir Disoproxil Fumarate (TDF) 300 mg + Lamivudine (3TC) 300 mg + Efavirenz (EFV) 600 mgAbacavir (ABC) 600 mg + Lamivudine (3TC) 300 mg + Efavirenz (EFV) 600 mgZidovudine (AZT) 300 mg + Lamivudine (3TC) 150 mg twice daily + Efavirenz (EFV) 600 mg once daily

Obafemi Awolowo University194 participants4 sites · NigeriaCompletes Dec 2019

Compare CT.gov Full analysis →

Completed

Results posted

Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8558 Monotherapy in Anti-Retroviral-Naïve HIV-1 Infected Participants (MK-8558-002)

Phase 1HIV-1 Infection

MK-8558

Merck Sharp & Dohme LLC21 participants2 sites · Germany, RomaniaCompletes May 2020

Compare CT.gov Full analysis →

Completed

Practice of "Chemical Sex" by HIV Patients in Reunion Island

N/AHIV

Survey

Centre Hospitalier Universitaire de la Réunion245 participants1 site · ReunionCompletes Jul 2018

Compare CT.gov Full analysis →

Completed

Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals

N/APatient AdherenceHIV Seronegativity

brief Motivational Interviewing

University of California, San Diego263 participants5 sites · United StatesCompletes Sep 2020

Compare CT.gov Full analysis →

Completed

Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi

N/AKaposi SarcomaHIV

UNC Lineberger Comprehensive Cancer Center157 participants2 sites · MalawiCompletes Oct 2020

Compare CT.gov Full analysis →

Completed

Results posted

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Phase 4Hepatitis C, ChronicHIV

Pegylated interferon alpha-2aRibavirinBoceprevir

Markus Peck-Radosavljevic6 participants1 site · AustriaCompletes Jun 2015

Compare CT.gov Full analysis →

Completed

Results posted

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Phase 2Phase 3HIV Infections

NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)NNRTIs (EFV, NVP)PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)

National Institute of Allergy and Infectious Diseases (NIAID)266 participants31 sites · United States, Puerto RicoCompletes Aug 2009

Compare CT.gov Full analysis →

Completed

Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER

N/ADrug UseSex Behavior

Brief Intervention

University of Michigan63 participants1 site · United StatesCompletes Aug 2018

Compare CT.gov Full analysis →

Completed

Results posted

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding

Phase 3HIV Infections

NevirapineNevirapine placebo

National Institute of Allergy and Infectious Diseases (NIAID)2,026 participants5 sites · South Africa, Tanzania, UgandaCompletes Sep 2011

Compare CT.gov Full analysis →

1–15 of 12,083

Explore/HIV Infections

Status

Phase

12,083 results for “HIV Infections”

Page 1 of 806

Completed

Supporting Sustained HIV Treatment Adherence After Initiation

N/AHIV InfectionsAdherence, Medication

Boston University534 participants3 sites · South AfricaCompletes May 2026

Compare CT.gov Full analysis →

Active

A Prospective Cohort for ex Vivo Cure Studies With Chronic HIV Infected Patients in the Netherlands

N/AHIV InfectionsHIV-1-infectionHIV-2 Infection

Erasmus Medical Center35 participants1 site · NetherlandsCompletes Jan 2027

Compare CT.gov Full analysis →

Completed

Respiratory Virus Outpatient Study (FLU 002 Plus)

N/AInfluenza and Other Novel Respiratory Viruses

University of Minnesota11,719 participants68 sites · United States, Argentina, AustraliaCompletes May 2017

Compare CT.gov Full analysis →

Recruiting

Sorfequiline-based Regimens in Adults With Newly Diagnosed Drug-sensitive Pulmonary TB

Phase 2Tuberculosis, Pulmonary

sorfequilinePretomanidLinezolid

Global Alliance for TB Drug Development100 participants12 sites · South Africa, TanzaniaCompletes May 2027

Compare CT.gov Full analysis →

Completed

Results posted

Injectable Cabotegravir Compared to TDF/FTC For PrEP in HIV-Uninfected Men and Transgender Women Who Have Sex With Men

Phase 2Phase 3HIV Infections

Cabotegravir Oral TabletTDF/FTC tabletsPlacebo for TDF/FTC tablets+3 more

National Institute of Allergy and Infectious Diseases (NIAID)4,570 participants43 sites · United States, Argentina, BrazilCompletes May 2020

Compare CT.gov Full analysis →

Completed

Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU

N/AHIV

Individual levelStructural levelIndividual level standard of care+1 more

Johns Hopkins Bloomberg School of Public Health2,175 participants1 site · VietnamCompletes Apr 2013

Compare CT.gov Full analysis →

Completed

Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids

N/AHuman Immunodeficiency Virus Infection

Obafemi Awolowo University194 participants4 sites · NigeriaCompletes Dec 2019

Compare CT.gov Full analysis →

Completed

Results posted

Safety, Tolerability, Pharmacokinetics, and Anti-Retroviral Activity of MK-8558 Monotherapy in Anti-Retroviral-Naïve HIV-1 Infected Participants (MK-8558-002)

Phase 1HIV-1 Infection

MK-8558

Merck Sharp & Dohme LLC21 participants2 sites · Germany, RomaniaCompletes May 2020

Compare CT.gov Full analysis →

Completed

Practice of "Chemical Sex" by HIV Patients in Reunion Island

N/AHIV

Survey

Centre Hospitalier Universitaire de la Réunion245 participants1 site · ReunionCompletes Jul 2018

Compare CT.gov Full analysis →

Completed

Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals

N/APatient AdherenceHIV Seronegativity

brief Motivational Interviewing

University of California, San Diego263 participants5 sites · United StatesCompletes Sep 2020

Compare CT.gov Full analysis →

Completed

Investigating Chemotherapy Treatments, Response and Subsets of HIV-associated Kaposi Sarcoma in Malawi

N/AKaposi SarcomaHIV

UNC Lineberger Comprehensive Cancer Center157 participants2 sites · MalawiCompletes Oct 2020

Compare CT.gov Full analysis →

Completed

Results posted

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

Phase 4Hepatitis C, ChronicHIV

Pegylated interferon alpha-2aRibavirinBoceprevir

Markus Peck-Radosavljevic6 participants1 site · AustriaCompletes Jun 2015

Compare CT.gov Full analysis →

Completed

Results posted

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children

Phase 2Phase 3HIV Infections

NRTIs (ABC, FTC, FTC/TDF, 3TC, 3TC/AZT, d4T, TDF, ddC, AZT)NNRTIs (EFV, NVP)PIs (AMP, IDV, LPV/r, NFV, SQV, RTV)

National Institute of Allergy and Infectious Diseases (NIAID)266 participants31 sites · United States, Puerto RicoCompletes Aug 2009

Compare CT.gov Full analysis →

Completed

Drug Use and Sexual Risk Behaviors Among Emerging Adults in the ER

N/ADrug UseSex Behavior

Brief Intervention

University of Michigan63 participants1 site · United StatesCompletes Aug 2018

Compare CT.gov Full analysis →

Completed

Results posted

Using Nevirapine to Prevent Mother-to-Child HIV Transmission During Breastfeeding

Phase 3HIV Infections

NevirapineNevirapine placebo

National Institute of Allergy and Infectious Diseases (NIAID)2,026 participants5 sites · South Africa, Tanzania, UgandaCompletes Sep 2011

Compare CT.gov Full analysis →

1–15 of 12,083